Chondrocyte-specific microRNA-140 regulates endochondral bone development and targets Dnpep to modulate bone morphogenetic protein signaling.

PubWeight™: 1.24‹?› | Rank: Top 10%

🔗 View Article (PMC 3133397)

Published in Mol Cell Biol on May 16, 2011

Authors

Yukio Nakamura1, Jennifer B Inloes, Takenobu Katagiri, Tatsuya Kobayashi

Author Affiliations

1: Clinical Research Center, Murayama Medical Center, Tokyo 208-0011, Japan.

Articles citing this

MicroRNA control of bone formation and homeostasis. Nat Rev Endocrinol (2012) 2.05

Epigenomic and microRNA-mediated regulation in cartilage development, homeostasis, and osteoarthritis. Trends Mol Med (2011) 1.40

Macro view of microRNA function in osteoarthritis. Nat Rev Rheumatol (2012) 1.33

Molecular characterization of the microRNA-138-Fos-like antigen 1 (FOSL1) regulatory module in squamous cell carcinoma. J Biol Chem (2011) 1.00

let-7 and miR-140 microRNAs coordinately regulate skeletal development. Proc Natl Acad Sci U S A (2013) 0.98

MicroRNAs as novel regulators of stem cell fate. World J Stem Cells (2013) 0.94

MicroRNAs involved in bone formation. Cell Mol Life Sci (2014) 0.92

MicroRNAs as regulators of bone homeostasis and bone metastasis. Bonekey Rep (2014) 0.90

MicroRNAs in cartilage development, homeostasis, and disease. Curr Osteoporos Rep (2014) 0.89

Structure of human aspartyl aminopeptidase complexed with substrate analogue: insight into catalytic mechanism, substrate specificity and M18 peptidase family. BMC Struct Biol (2012) 0.88

TGF-β and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and disease. Bone Res (2016) 0.88

Matrix vesicles: Are they anchored exosomes? Bone (2015) 0.88

Prenatal exposure to TCDD triggers significant modulation of microRNA expression profile in the thymus that affects consequent gene expression. PLoS One (2012) 0.87

MicroRNA-140 promotes adipocyte lineage commitment of C3H10T1/2 pluripotent stem cells via targeting osteopetrosis-associated transmembrane protein 1. J Biol Chem (2013) 0.85

microRNA-495 inhibits chondrogenic differentiation in human mesenchymal stem cells by targeting Sox9. Stem Cells Dev (2014) 0.85

Next-generation sequencing identifies equine cartilage and subchondral bone miRNAs and suggests their involvement in osteochondrosis physiopathology. BMC Genomics (2014) 0.83

Genome-Wide MicroRNA and Gene Analysis of Mesenchymal Stem Cell Chondrogenesis Identifies an Essential Role and Multiple Targets for miR-140-5p. Stem Cells (2015) 0.81

Developmental epigenetics of the murine secondary palate. ILAR J (2012) 0.81

Current Status and Strategy of microRNA Research for Cartilage Development and Osteoarthritis Pathogenesis. J Bone Metab (2016) 0.81

MicroRNA Mechanisms of Action: What have We Learned from Mice? Front Genet (2015) 0.80

Upregulation of miR-23b enhances the autologous therapeutic potential for degenerative arthritis by targeting PRKACB in synovial fluid-derived mesenchymal stem cells from patients. Mol Cells (2014) 0.80

The microRNA-29 family in cartilage homeostasis and osteoarthritis. J Mol Med (Berl) (2015) 0.78

Molecular basis of cleft palates in mice. World J Biol Chem (2015) 0.78

Differentially expressed microRNAs in chondrocytes from distinct regions of developing human cartilage. PLoS One (2013) 0.78

Identification of a novel FGFRL1 MicroRNA target site polymorphism for bone mineral density in meta-analyses of genome-wide association studies. Hum Mol Genet (2015) 0.78

Detecting new microRNAs in human osteoarthritic chondrocytes identifies miR-3085 as a human, chondrocyte-selective, microRNA. Osteoarthritis Cartilage (2015) 0.78

MicroRNA-140 Provides Robustness to the Regulation of Hypertrophic Chondrocyte Differentiation by the PTHrP-HDAC4 Pathway. J Bone Miner Res (2015) 0.78

HIF-1 α had pivotal effects on downregulation of miR-210 decreasing viability and inducing apoptosis in hypoxic chondrocytes. ScientificWorldJournal (2014) 0.78

A conditional system to specifically link disruption of protein-coding function with reporter expression in mice. Cell Rep (2014) 0.77

The Role of miRNAs in Common Inflammatory Arthropathies: Osteoarthritis and Gouty Arthritis. Biomolecules (2016) 0.77

Runx2 and microRNA regulation in bone and cartilage diseases. Ann N Y Acad Sci (2016) 0.76

Profiling microRNA expression during fracture healing. BMC Musculoskelet Disord (2016) 0.76

Identification and characterization of novel inhibitors of Mammalian aspartyl aminopeptidase. Mol Pharmacol (2014) 0.76

Hydrostatic Pressure Regulates MicroRNA Expression Levels in Osteoarthritic Chondrocyte Cultures via the Wnt/β-Catenin Pathway. Int J Mol Sci (2017) 0.76

miRNAs in Bone Development. Curr Genomics (2015) 0.75

Roles of microRNA and signaling pathway in osteoarthritis pathogenesis. J Zhejiang Univ Sci B (2016) 0.75

The Role of miRNAs in Cartilage Homeostasis. Curr Genomics (2015) 0.75

Polycomb repressive complex 2 regulates skeletal growth by suppressing Wnt and TGF-β signalling. Nat Commun (2016) 0.75

Epigenetic and microRNA regulation during osteoarthritis development. F1000Res (2015) 0.75

Inflammation and epigenetic regulation in osteoarthritis. Connect Tissue Res (2016) 0.75

Bone marrow stroma-derived miRNAs as regulators, biomarkers and therapeutic targets of bone metastasis. Bonekey Rep (2015) 0.75

Decoding the Regulatory Landscape of Ageing in Musculoskeletal Engineered Tissues Using Genome-Wide DNA Methylation and RNASeq. PLoS One (2016) 0.75

miRNAs in circulation: mirroring bone conditions? J Bone Miner Res (2014) 0.75

Role of Osterix and MicroRNAs in Bone Formation and Tooth Development. Med Sci Monit (2016) 0.75

Regulation of Long Bone Growth in Vertebrates; It Is Time to Catch Up. Endocr Rev (2015) 0.75

MicroRNA profiling of antler stem cells in potentiated and dormant states and their potential roles in antler regeneration. Mol Genet Genomics (2016) 0.75

miR-27 regulates chondrogenesis by suppressing Focal Adhesion Kinase during pharyngeal arch development. Dev Biol (2017) 0.75

Articles cited by this

MicroRNAs: target recognition and regulatory functions. Cell (2009) 92.17

Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature (2010) 22.04

MicroRNA expression in zebrafish embryonic development. Science (2005) 15.52

Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev (2006) 15.20

Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science (2007) 12.42

High-efficiency deleter mice show that FLPe is an alternative to Cre-loxP. Nat Genet (2000) 11.80

The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev (2007) 10.15

PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth. Science (1996) 6.33

Hybrid vigor, fetal overgrowth, and viability of mice derived by nuclear cloning and tetraploid embryo complementation. Proc Natl Acad Sci U S A (2001) 5.76

Differential staining of cartilage and bone in whole mouse fetuses by alcian blue and alizarin red S. Teratology (1980) 5.59

Isolation of microRNA targets by miRNP immunopurification. RNA (2007) 5.50

Canalization of development by microRNAs. Nat Genet (2006) 5.46

A biochemical approach to identifying microRNA targets. Proc Natl Acad Sci U S A (2007) 5.16

Identification of human microRNA targets from isolated argonaute protein complexes. RNA Biol (2007) 4.96

Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Dev (1994) 4.58

Revisiting the principles of microRNA target recognition and mode of action. Nat Rev Mol Cell Biol (2009) 4.38

Systematic identification of C. elegans miRISC proteins, miRNAs, and mRNA targets by their interactions with GW182 proteins AIN-1 and AIN-2. Mol Cell (2007) 4.22

RNA secondary structure prediction by centroids in a Boltzmann weighted ensemble. RNA (2005) 3.80

Col2a1-directed expression of Cre recombinase in differentiating chondrocytes in transgenic mice. Genesis (2000) 3.74

Systematic identification of mRNAs recruited to argonaute 2 by specific microRNAs and corresponding changes in transcript abundance. PLoS One (2008) 3.38

Dicer-dependent pathways regulate chondrocyte proliferation and differentiation. Proc Natl Acad Sci U S A (2008) 3.10

Molecular genetics of axis formation in zebrafish. Annu Rev Genet (2005) 3.06

MicroRNA Mirn140 modulates Pdgf signaling during palatogenesis. Nat Genet (2008) 3.01

Bmpr1a and Bmpr1b have overlapping functions and are essential for chondrogenesis in vivo. Proc Natl Acad Sci U S A (2005) 2.82

The cartilage specific microRNA-140 targets histone deacetylase 4 in mouse cells. FEBS Lett (2006) 2.79

MicroRNA-140 plays dual roles in both cartilage development and homeostasis. Genes Dev (2010) 2.70

Interaction of FGF, Ihh/Pthlh, and BMP signaling integrates chondrocyte proliferation and hypertrophic differentiation. Dev Cell (2002) 2.37

The regulation of genes and genomes by small RNAs. Development (2007) 2.23

BMP canonical Smad signaling through Smad1 and Smad5 is required for endochondral bone formation. Development (2009) 2.21

PTHrP and Indian hedgehog control differentiation of growth plate chondrocytes at multiple steps. Development (2002) 2.19

Cell autonomous requirement for PDGFRalpha in populations of cranial and cardiac neural crest cells. Development (2003) 2.07

Indian hedgehog stimulates periarticular chondrocyte differentiation to regulate growth plate length independently of PTHrP. J Clin Invest (2005) 1.82

Identification of a BMP-responsive element in Id1, the gene for inhibition of myogenesis. Genes Cells (2002) 1.80

Analysis of microRNA knockouts in mice. Hum Mol Genet (2010) 1.59

Experimental identification of microRNA targets. Gene (2009) 1.36

The chick transcriptional repressor Nkx3.2 acts downstream of Shh to promote BMP-dependent axial chondrogenesis. Dev Cell (2001) 1.31

Experimental identification of microRNA-140 targets by silencing and overexpressing miR-140. RNA (2008) 1.29

The CCN family member Wisp3, mutant in progressive pseudorheumatoid dysplasia, modulates BMP and Wnt signaling. J Clin Invest (2007) 1.19

An in vivo reporter of BMP signaling in organogenesis reveals targets in the developing kidney. BMC Dev Biol (2008) 1.12

Labeled microRNA pull-down assay system: an experimental approach for high-throughput identification of microRNA-target mRNAs. Nucleic Acids Res (2009) 1.09

Brain aminopeptidases and hypertension. J Renin Angiotensin Aldosterone Syst (2006) 0.82

Articles by these authors

Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia. Nature (2010) 5.43

Osteoblast precursors, but not mature osteoblasts, move into developing and fractured bones along with invading blood vessels. Dev Cell (2010) 4.99

Endogenous bone marrow MSCs are dynamic, fate-restricted participants in bone maintenance and regeneration. Cell Stem Cell (2012) 4.67

Retracted DEAD-box RNA helicase subunits of the Drosha complex are required for processing of rRNA and a subset of microRNAs. Nat Cell Biol (2007) 4.45

BMP type I receptor inhibition reduces heterotopic [corrected] ossification. Nat Med (2008) 4.20

Notch signaling maintains bone marrow mesenchymal progenitors by suppressing osteoblast differentiation. Nat Med (2008) 3.64

PTHrP and Indian hedgehog control differentiation of growth plate chondrocytes at multiple steps. Development (2002) 2.19

The fibrodysplasia ossificans progressiva R206H ACVR1 mutation activates BMP-independent chondrogenesis and zebrafish embryo ventralization. J Clin Invest (2009) 2.18

miR-125b inhibits osteoblastic differentiation by down-regulation of cell proliferation. Biochem Biophys Res Commun (2008) 2.16

Osteoblast-derived PTHrP is a potent endogenous bone anabolic agent that modifies the therapeutic efficacy of administered PTH 1-34. J Clin Invest (2005) 1.88

Constitutively activated ALK2 and increased SMAD1/5 cooperatively induce bone morphogenetic protein signaling in fibrodysplasia ossificans progressiva. J Biol Chem (2008) 1.88

BMP signaling negatively regulates bone mass through sclerostin by inhibiting the canonical Wnt pathway. Development (2008) 1.86

Bradykinin decreases plasminogen activator inhibitor-1 expression and facilitates matrix degradation in the renal tubulointerstitium under angiotensin-converting enzyme blockade. J Am Soc Nephrol (2004) 1.61

Sulfated polysaccharides enhance the biological activities of bone morphogenetic proteins. J Biol Chem (2003) 1.59

Deletion of Vhlh in chondrocytes reduces cell proliferation and increases matrix deposition during growth plate development. Development (2004) 1.58

Effect of acute and long-term aerobic exercise on arterial stiffness in the elderly. Hypertens Res (2007) 1.55

Wnt inhibitors Dkk1 and Sost are downstream targets of BMP signaling through the type IA receptor (BMPRIA) in osteoblasts. J Bone Miner Res (2010) 1.54

Disruption of BMP signaling in osteoblasts through type IA receptor (BMPRIA) increases bone mass. J Bone Miner Res (2008) 1.54

Connective tissue growth factor expressed in tubular epithelium plays a pivotal role in renal fibrogenesis. J Am Soc Nephrol (2004) 1.53

Targeted ablation of the PTH/PTHrP receptor in osteocytes impairs bone structure and homeostatic calcemic responses. J Endocrinol (2011) 1.50

Involvement of endogenous bone morphogenetic protein (BMP) 2 and BMP6 in bone formation. J Biol Chem (2005) 1.47

miR-210 promotes osteoblastic differentiation through inhibition of AcvR1b. FEBS Lett (2009) 1.46

ADAMTS-7, a direct target of PTHrP, adversely regulates endochondral bone growth by associating with and inactivating GEP growth factor. Mol Cell Biol (2009) 1.46

Heparin potentiates the in vivo ectopic bone formation induced by bone morphogenetic protein-2. J Biol Chem (2006) 1.45

Skeletal metamorphosis in fibrodysplasia ossificans progressiva (FOP). J Bone Miner Metab (2008) 1.41

Cross-talk between Wnt and bone morphogenetic protein 2 (BMP-2) signaling in differentiation pathway of C2C12 myoblasts. J Biol Chem (2005) 1.39

Chondrocyte-specific knockout of the G protein G(s)alpha leads to epiphyseal and growth plate abnormalities and ectopic chondrocyte formation. J Bone Miner Res (2004) 1.37

Wwp2 is essential for palatogenesis mediated by the interaction between Sox9 and mediator subunit 25. Nat Commun (2011) 1.27

In vivo evidence that BMP signaling is necessary for apoptosis in the mouse limb. Dev Biol (2002) 1.27

Tumor necrosis factor alpha represses bone morphogenetic protein (BMP) signaling by interfering with the DNA binding of Smads through the activation of NF-kappaB. J Biol Chem (2009) 1.24

Transcriptional regulation of Smad2 is required for enhancement of TGFbeta/Smad signaling by TGFbeta inducible early gene. J Cell Biochem (2002) 1.22

A novel transgenic mouse model to study the osteoblast lineage in vivo. Ann N Y Acad Sci (2007) 1.18

Parathyroid hormone/parathyroid hormone-related protein receptor signaling is required for maintenance of the growth plate in postnatal life. Proc Natl Acad Sci U S A (2010) 1.14

Radial augmentation index: a useful and easily obtainable parameter for vascular aging. Am J Hypertens (2005) 1.12

Hepatocyte growth factor counteracts transforming growth factor-beta1, through attenuation of connective tissue growth factor induction, and prevents renal fibrogenesis in 5/6 nephrectomized mice. FASEB J (2002) 1.10

Id4, a new candidate gene for senile osteoporosis, acts as a molecular switch promoting osteoblast differentiation. PLoS Genet (2010) 1.09

BMP3 suppresses osteoblast differentiation of bone marrow stromal cells via interaction with Acvr2b. Mol Endocrinol (2011) 1.08

Bone morphogenetic protein-2 down-regulates miR-206 expression by blocking its maturation process. Biochem Biophys Res Commun (2009) 1.06

A unique mutation of ALK2, G356D, found in a patient with fibrodysplasia ossificans progressiva is a moderately activated BMP type I receptor. Biochem Biophys Res Commun (2008) 1.05

Purification and identification of a BMP-like factor from bovine serum. Biochem Biophys Res Commun (2006) 1.04

Gamma knife stereotactic radiosurgery for atypical and malignant meningiomas. Acta Neurochir Suppl (2013) 1.03

Disruption of PTH receptor 1 in T cells protects against PTH-induced bone loss. PLoS One (2010) 1.03

Bone formation enhanced by implanted octacalcium phosphate involving conversion into Ca-deficient hydroxyapatite. Biomaterials (2006) 1.01

Adenomatous polyposis coli-mediated control of beta-catenin is essential for both chondrogenic and osteogenic differentiation of skeletal precursors. BMC Dev Biol (2009) 0.99

let-7 and miR-140 microRNAs coordinately regulate skeletal development. Proc Natl Acad Sci U S A (2013) 0.98

Dual roles of smad proteins in the conversion from myoblasts to osteoblastic cells by bone morphogenetic proteins. J Biol Chem (2010) 0.98

Interleukin-4 inhibition of osteoclast differentiation is stronger than that of interleukin-13 and they are equivalent for induction of osteoprotegerin production from osteoblasts. Immunology (2007) 0.98

Role of osteoglycin in the linkage between muscle and bone. J Biol Chem (2012) 0.98

Histopathological and ultrastructural features of Koi herpesvirus (KHV)-infected carp Cyprinus carpio, and the morphology and morphogenesis of KHV. Dis Aquat Organ (2008) 0.94

Deformity of the great toe in fibrodysplasia ossificans progressiva. J Orthop Sci (2010) 0.93

Platelet-rich plasma stimulates osteoblastic differentiation in the presence of BMPs. Biochem Biophys Res Commun (2007) 0.93

Canonical Wnts and BMPs cooperatively induce osteoblastic differentiation through a GSK3beta-dependent and beta-catenin-independent mechanism. Differentiation (2010) 0.93

Protein phosphatase magnesium-dependent 1A-mediated inhibition of BMP signaling is independent of Smad dephosphorylation. J Bone Miner Res (2010) 0.93

Long-term outcomes in patients with vestibular schwannomas treated using gamma knife surgery: 10-year follow up. J Neurosurg (2005) 0.92

MicroRNAs involved in bone formation. Cell Mol Life Sci (2014) 0.92

Sox9 is upstream of microRNA-140 in cartilage. Appl Biochem Biotechnol (2011) 0.92

Gp130-mediated signaling is necessary for normal osteoblastic function in vivo and in vitro. Endocrinology (2003) 0.91

Early clinical and radiographic characteristics in fibrodysplasia ossificans progressiva: a report of two cases. J Bone Joint Surg Am (2011) 0.91

A novel mutation of ALK2, L196P, found in the most benign case of fibrodysplasia ossificans progressiva activates BMP-specific intracellular signaling equivalent to a typical mutation, R206H. Biochem Biophys Res Commun (2011) 0.90

Stereotactic radiosurgery for metastatic tumors in the pituitary gland and the cavernous sinus. J Neurosurg (2006) 0.90

MicroRNAs in cartilage development, homeostasis, and disease. Curr Osteoporos Rep (2014) 0.89

Stereotactic radiotherapy using Novalis for craniopharyngioma adjacent to optic pathways. J Neurooncol (2010) 0.88

Effect of demecolcine and nocodazole on the efficiency of chemically assisted removal of chromosomes and the developmental potential of nuclear transferred porcine oocytes. Cloning Stem Cells (2003) 0.88

Suppression of BMP-Smad signaling axis-induced osteoblastic differentiation by small C-terminal domain phosphatase 1, a Smad phosphatase. Mol Endocrinol (2011) 0.88

Complete anterior knee dislocation 16 years after cruciate-retaining total knee arthroplasty. Orthopedics (2012) 0.87

Identification of a novel bone morphogenetic protein (BMP)-inducible transcript, BMP-inducible transcript-1, by utilizing the conserved BMP-responsive elements in the Id genes. J Bone Miner Metab (2012) 0.87

Establishment of a novel method for enriching osteoblast progenitors from adipose tissues using a difference in cell adhesive properties. Biochem Biophys Res Commun (2006) 0.87

Angiotensin II type 1 receptor blockade attenuates renal fibrogenesis in an immune-mediated nephritic kidney through counter-activation of angiotensin II type 2 receptor. Biochem Biophys Res Commun (2004) 0.87

Trigeminal neuralgia caused by nerve compression by dilated superior cerebellar artery associated with cerebellar arteriovenous malformation: case report. Neurol Med Chir (Tokyo) (2013) 0.86

The utility of formalin-fixed and paraffin-embedded tissue blocks for quantitative analysis of N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase mRNA expressed by colorectal cancer cells. Acta Histochem Cytochem (2007) 0.86

Identification and functional analysis of Zranb2 as a novel Smad-binding protein that suppresses BMP signaling. J Cell Biochem (2012) 0.86

Selective depletion of fibroblasts preserves morphology and the functional integrity of peritoneum in transgenic mice with peritoneal fibrosing syndrome. Kidney Int (2003) 0.86

Cyclic AMP enhances Smad-mediated BMP signaling through PKA-CREB pathway. J Bone Miner Metab (2008) 0.86

Assessment of spatial uncertainties in the radiotherapy process with the Novalis system. Int J Radiat Oncol Biol Phys (2009) 0.85

Stereotactic radiotherapy using Novalis for skull base metastases developing with cranial nerve symptoms. J Neurooncol (2010) 0.85

Stereotactic radiosurgery for pineal and related tumors. Prog Neurol Surg (2009) 0.84

Hypofractionated stereotactic body radiotherapy for primary and metastatic liver tumors using the novalis image-guided system: preliminary results regarding efficacy and toxicity. Technol Cancer Res Treat (2010) 0.84

Gamma knife radiosurgery of brain metastasis from malignant pleural mesothelioma--report of three cases with autopsy study in a case. Nagoya J Med Sci (2014) 0.84

Isolated cerebral varix developing sudden deterioration of neurological status because of thrombosis: a case report. Surg Neurol (2004) 0.84

[Association with relative nocturnal polyuria using BNP (brain natriuretic peptide) in eldely patients with nocturia]. Nihon Hinyokika Gakkai Zasshi (2007) 0.83

Lactacystin, a proteasome inhibitor, enhances BMP-induced osteoblastic differentiation by increasing active Smads. Biochem Biophys Res Commun (2011) 0.83

An atypical pattern of Epstein-Barr virus infection in a case with idiopathic tubulointerstitial nephritis. Nephron (2002) 0.83

Tubular expression of connective tissue growth factor correlates with interstitial fibrosis in type 2 diabetic nephropathy. Nephrol Dial Transplant (2005) 0.83

Thyroid hormone stimulates osteoclast differentiation by a mechanism independent of RANKL-RANK interaction. J Cell Physiol (2004) 0.83

Interaction of Tmem119 and the bone morphogenetic protein pathway in the commitment of myoblastic into osteoblastic cells. Bone (2012) 0.83

Enantioselective total synthesis of (+)-tricycloclavulone. J Am Chem Soc (2004) 0.82

FGF23 induces expression of two isoforms of NAB2, which are corepressors of Egr-1. Biochem Biophys Res Commun (2006) 0.82

Stereotactic radiosurgery as a salvage treatment for recurrent skull base adenoid cystic carcinoma. Stereotact Funct Neurosurg (2006) 0.82

HNK-1 glycan functions as a tumor suppressor for astrocytic tumor. J Biol Chem (2011) 0.82

Stereotactic radiotherapy for spinal intradural metastases developing within or adjacent to the previous irradiation field--report of three cases. Nagoya J Med Sci (2013) 0.82

Accumulation of p100, a precursor of NF-κB2, enhances osteoblastic differentiation in vitro and bone formation in vivo in aly/aly mice. Mol Endocrinol (2012) 0.82

Effects of endocrine disrupting substance on estrogen receptor gene transcription in dialysis patients. Ther Apher Dial (2007) 0.82

Clinically applicable antianginal agents suppress osteoblastic transformation of myogenic cells and heterotopic ossifications in mice. J Bone Miner Metab (2012) 0.82

Transgene-derived hepatocyte growth factor attenuates reactive renal fibrosis in aristolochic acid nephrotoxicity. Nephrol Dial Transplant (2003) 0.81

Increases in the number of brain metastases detected at frame-fixed, thin-slice MRI for gamma knife surgery planning. Neuro Oncol (2010) 0.81

Interstitial fibroblast-like cells express renin-angiotensin system components in a fibrosing murine kidney. Am J Pathol (2002) 0.81

Useful base plate to support the head during Leksell skull frame placement in gamma knife perfexion radiosurgery. Nagoya J Med Sci (2014) 0.81

TGF-beta1 and HGF coordinately facilitate collagen turnover in subepithelial mesenchyme. Biochem Biophys Res Commun (2002) 0.81

Malignant lymphoma arising in the cerebral parenchyma adjacent to a parasagittal meningioma. Neurol Med Chir (Tokyo) (2006) 0.81